Michael Kauffman Transaction History

Date Transaction Value Shares Traded Form
Feb 28 2022
SELL
Open market or private sale
$63,754 $10.24 p/Share
6,226
Feb 17 2022
SELL
Open market or private sale
$110,147 $12.12 p/Share
9,088
Feb 07 2022
SELL
Open market or private sale
$66,131 $9.86 p/Share
6,707
Feb 25 2021
BUY
Grant, award, or other acquisition
-
57,200
Feb 18 2021
SELL
Open market or private sale
$140,811 $14.83 p/Share
9,495
Feb 15 2021
BUY
Exercise of conversion of derivative security
-
21,800
Feb 11 2021
SELL
Open market or private sale
$103,084 $15.52 p/Share
6,642
Feb 05 2021
BUY
Exercise of conversion of derivative security
-
14,300
Oct 12 2020
SELL
Open market or private sale
$111,675 $14.89 p/Share
7,500
Oct 12 2020
BUY
Exercise of conversion of derivative security
$225 $0.03 p/Share
7,500

Also insider at

ACET
Adicet Bio, Inc. Healthcare
KZR
Kezar Life Sciences, Inc. Healthcare
VSTM
Verastem, Inc. Healthcare
MK

Michael Kauffman

Director
Newton, MA

Track Institutional and Insider Activities on KPTI

Follow Karyopharm Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPTI shares.

Notify only if

Insider Trading

Get notified when an Karyopharm Therapeutics Inc. insider buys or sells KPTI shares.

Notify only if

News

Receive news related to Karyopharm Therapeutics Inc.

Track Activities on KPTI